Alikem Limited (AKE.CA) Stock Price & Overview

TSX:AKEAU0000193666

Current stock price

8.86 CAD
-0.05 (-0.56%)
Last:

The current stock price of AKE.CA is 8.86 CAD. Today AKE.CA is down by -0.56%. In the past month the price increased by 13.74%. In the past year, price decreased by -15.78%.

AKE.CA Key Statistics

52-Week Range7.36 - 15.19
Current AKE.CA stock price positioned within its 52-week range.
1-Month Range7.36 - 10
Current AKE.CA stock price positioned within its 1-month range.
Market Cap
5.68B
P/E
9.53
Fwd P/E
11.57
EPS (TTM)
0.93
Dividend Yield
N/A

AKE.CA Stock Performance

Today
-0.56%
1 Week
-6.44%
1 Month
+13.74%
3 Months
-12.62%
Longer-term
6 Months -35.52%
1 Year -15.78%
2 Years -8.00%
3 Years N/A
5 Years N/A
10 Years N/A

AKE.CA Stock Chart

Alikem Limited / AKE Daily stock chart

AKE.CA Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to AKE.CA. When comparing the yearly performance of all stocks, AKE.CA is a bad performer in the overall market: 72.06% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AKE.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to AKE.CA. Both the health and profitability get an excellent rating, making AKE.CA a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AKE.CA Earnings

Next Earnings DateJan 4, 2022
Last Earnings DateN/A
PeriodQ4 / 2023
EPS Reported$0.42
Revenue Reported
EPS Surprise -6.68%
Revenue Surprise -3.76%

AKE.CA Forecast & Estimates

21 analysts have analysed AKE.CA and the average price target is 12.46 CAD. This implies a price increase of 40.6% is expected in the next year compared to the current price of 8.86.

For the next year, analysts expect an EPS growth of -17.91% and a revenue growth -5.44% for AKE.CA


Analysts
Analysts78.1
Price Target12.46 (40.63%)
EPS Next Y-17.91%
Revenue Next Year-5.44%

AKE.CA Groups

Sector & Classification

Index Membership

AKE.CA Financial Highlights

Over the last trailing twelve months AKE.CA reported a non-GAAP Earnings per Share(EPS) of 0.93. The EPS increased by 28.94% compared to the year before.


Income Statements
Revenue(TTM)1.21B
Net Income(TTM)441.71M
Industry RankSector Rank
PM (TTM) 36.57%
ROA 8.47%
ROE 12.98%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%-9.87%
Sales Q2Q%15.2%
EPS 1Y (TTM)28.94%
Revenue 1Y (TTM)62.19%

AKE.CA Ownership

Ownership
Inst Owners21.93%
Shares641.10M
Float595.25M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About AKE.CA

Company Profile

AKE logo image Allkem Ltd. operates as a lithium chemicals company and borates producer with a global portfolio of diverse and lithium chemicals. The company is headquartered in Brisbane, Queensland and currently employs 1,350 full-time employees. The company went IPO on 2007-12-04. The firm is principally engaged in mineral extraction, production, and chemical processing. The Company’s segments include Olaroz, Mt Cattlin, James Bay, Sal De Vida projects, and Corporate. Its flagship Olaroz brine-based lithium facility is based in Northern Argentina and supplies lithium chemicals across the globe. The Mt Cattlin spodumene project (Mt Cattlin) produces spodumene concentrate utilizing conventional techniques to extract and process the resource. This wholly owned project is located two kilometers (km) north of the town of Ravensthorpe in Western Australia. The James Bay Project is located in northern Quebec, approximately 130 km east of James Bay and the Cree Nation of Eastmain community. Sal De Vida project is a tier one brine project, which is located in Catamarca Province on the Salar del Hombre Muerto. Its other project includes Cauchari mineral resource.

Company Info

IPO: 2007-12-04

Alikem Limited

Level 35, 71 Eagle Street

Brisbane QUEENSLAND AU

Employees: 1350

AKE Company Website

Phone: 61738713985

Alikem Limited / AKE.CA FAQ

What does AKE do?

Allkem Ltd. operates as a lithium chemicals company and borates producer with a global portfolio of diverse and lithium chemicals. The company is headquartered in Brisbane, Queensland and currently employs 1,350 full-time employees. The company went IPO on 2007-12-04. The firm is principally engaged in mineral extraction, production, and chemical processing. The Company’s segments include Olaroz, Mt Cattlin, James Bay, Sal De Vida projects, and Corporate. Its flagship Olaroz brine-based lithium facility is based in Northern Argentina and supplies lithium chemicals across the globe. The Mt Cattlin spodumene project (Mt Cattlin) produces spodumene concentrate utilizing conventional techniques to extract and process the resource. This wholly owned project is located two kilometers (km) north of the town of Ravensthorpe in Western Australia. The James Bay Project is located in northern Quebec, approximately 130 km east of James Bay and the Cree Nation of Eastmain community. Sal De Vida project is a tier one brine project, which is located in Catamarca Province on the Salar del Hombre Muerto. Its other project includes Cauchari mineral resource.


Can you provide the latest stock price for Alikem Limited?

The current stock price of AKE.CA is 8.86 CAD. The price decreased by -0.56% in the last trading session.


What is the dividend status of Alikem Limited?

AKE.CA does not pay a dividend.


How is the ChartMill rating for Alikem Limited?

AKE.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Can you provide the PE ratio for AKE stock?

The PE ratio for Alikem Limited (AKE.CA) is 9.53. This is based on the reported non-GAAP earnings per share of 0.93 and the current share price of 8.86 CAD.


What is the market capitalization of AKE stock?

Alikem Limited (AKE.CA) has a market capitalization of 5.68B CAD. This makes AKE.CA a Mid Cap stock.